Buy Legal Cannabis in Australia — CBD, Medical Cannabis, and Hemp Explained
Legal cannabis access in Australia is far narrower than in the UK or US — this guide explains exactly what you can and can't buy without a prescription, why "legal CBD" is more complicated here than almost anywhere else, and the genuine pathways available to Australian buyers.
What You Can Buy Legally — And What You Can't
Australia treats cannabis and cannabinoids as regulated medicines, not consumer wellness products. This is the single most important difference from markets like the UK or US, where CBD is widely sold over the counter as a supplement. In Australia, CBD is scheduled under the national Poisons Standard, and — unlike hemp seed food products, which are genuinely unregulated and freely available — almost every cannabinoid product with real CBD or THC content requires a prescription to access lawfully.
This guide covers the four categories that actually exist under Australian law, and is explicit about the one category — over-the-counter CBD — that exists on paper but not yet in practice.
Category 1 — Medical Cannabis on Prescription
Medical cannabis has been legally accessible in Australia since 2016. Only two products — Sativex (nabiximols, for MS spasticity) and Epidyolex (CBD, for Dravet syndrome seizures) — are actually approved by the Therapeutic Goods Administration (TGA) and listed on the Australian Register of Therapeutic Goods (ARTG). Every other cannabis-based medicine prescribed in Australia, including most flower, oils, vapes, and capsules, is legally classed as "unapproved" — accessed through the TGA's Special Access Scheme (patient-specific approval) or the Authorised Prescriber pathway (approval to prescribe to a class of patients). This is the single functioning pathway for most Australians to legally access THC-containing cannabis products or higher-strength CBD.
Access is through an AHPRA-registered doctor, most commonly via a telehealth clinic. No GP referral is required at most clinics. See our full comparison of Australia's leading medical cannabis clinics for pricing and clinic-by-clinic detail.
Category 2 — Low-Dose CBD (Schedule 3)
In December 2020, the TGA down-scheduled certain low-dose CBD preparations from Schedule 4 (prescription-only) to Schedule 3 (pharmacist-only), effective 1 February 2021. In principle, this allows a pharmacist to supply an approved low-dose CBD product — up to 150mg/day, at least 98% CBD purity, no more than 1% THC, in oral or sublingual form only — to an adult without a prescription.
In practice, as of 2026, no CBD product has cleared the TGA's approval and ARTG registration requirements to actually be sold this way. The bar for safety, quality, and efficacy evidence at the required dose has proven difficult for manufacturers to clear. The result is a genuinely unusual situation: a legal pathway exists in law, but zero products currently use it. If you see a pharmacy or website claiming to sell "over-the-counter CBD" in Australia today, it is worth verifying that claim carefully — the honest current answer is that a prescription remains the only functioning route to legal CBD.
Category 3 — Hemp Food Products
Hemp seeds, hemp seed oil, and hemp protein powder are completely legal in Australia and widely available in supermarkets and health food shops, following Food Standards Australia New Zealand (FSANZ) approval of low-THC hemp foods in November 2017. Hemp seeds contain no significant cannabinoids — the seeds themselves carry negligible THC or CBD. Hemp seed oil, cold-pressed from the seeds, is a nutritionally dense source of omega fatty acids used in cooking and as a food supplement.
These products are frequently confused with CBD oil, but they are entirely different — hemp seed oil will not produce any cannabinoid effect and is regulated as a food, not a medicine. Always check the label: "hemp seed oil" is food; "CBD oil" is a scheduled medicine requiring prescription.
Category 4 — Industrial Hemp Cultivation
Low-THC industrial hemp — grown for fibre, building materials (hempcrete), textiles, and seed production — is legal to cultivate under state and territory licensing schemes across Australia, entirely separate from medicinal cannabis regulation. Industrial hemp crops must stay under a legislated THC threshold (commonly around 1%) and licensed growers are subject to state agricultural regulation rather than the TGA's medicines framework. This category has no consumer purchasing relevance beyond the hemp food and fibre products it produces — it is not a route to cannabinoid products.
How to Evaluate Medicinal Cannabis Product Quality
Because most medicinal cannabis products in Australia are legally "unapproved" — meaning the TGA has not itself assessed them — the burden of verifying quality shifts to the prescribing doctor and, ultimately, the patient. Here is how to evaluate quality effectively when a product is prescribed to you.
Certificate of Analysis — The Essential Requirement
Any medicinal cannabis product worth using has a published, batch-specific Certificate of Analysis (COA) confirming cannabinoid content matches the label, screening for pesticides, heavy metals, and microbial contamination, and ideally a full terpene panel. The testing laboratory should be independent of the manufacturer. Ask your prescribing doctor or pharmacy for the current COA for any product they dispense to you — reputable Australian medicinal cannabis brands make this readily available.
Full Spectrum, Broad Spectrum, and Isolate — What the Difference Means
Products are classified by cannabinoid composition. Full spectrum products contain THC and CBD alongside the complete range of minor cannabinoids and terpenes found in the plant. Broad spectrum products contain CBD and minor cannabinoids with THC removed — the option for patients who want breadth without any THC (relevant given Australia's zero-tolerance THC driving laws in most states). CBD isolate is 98%+ pure CBD with all other compounds removed, providing the most precise, consistent dosing.
Schedule Matters as Much as Formulation
In Australia, whether a product is Schedule 3, 4, or 8 changes both its legal access route and how it is regulated for quality. Schedule 8 (controlled drug) products — most THC-containing medicinal cannabis — face the strictest handling and prescribing controls. Ask your doctor which schedule your prescribed product falls under and what that means for repeat prescriptions, travel, and workplace drug testing.
Accessing Medical Cannabis in Australia — A Practical Guide
For patients who may benefit from medical cannabis, Australia has a functioning — though not PBS-subsidised — access route through AHPRA-registered doctors, most commonly via telehealth.
Step 1 — Assess Your Eligibility
Medical cannabis is most commonly prescribed in Australia for chronic pain, anxiety, PTSD, insomnia, fibromyalgia, ADHD, and cancer-related symptoms. Most clinics look for evidence that conventional treatments have been tried without adequate relief before considering cannabis-based medicine, though the threshold varies significantly between clinics.
Step 2 — Choose a Clinic
Australian telehealth medical cannabis clinics include Alternaleaf, Medio, Polln, Australian Access Clinics, and Cannalink Clinic, among others. Fees and clinical approach vary meaningfully — some clinics are vertically integrated with a cannabis supplier and dispensing pharmacy, while others are structurally independent. See our full clinic-by-clinic comparison for pricing, ownership structure, and patient reviews before choosing.
Step 3 — The Consultation Process
A doctor consultation — sometimes preceded by a free nurse screening — reviews your medical history, current medications, and symptoms to assess clinical appropriateness. If a prescription is issued, it specifies the exact product, dispensed through a partner pharmacy and delivered to your home, typically within days.
The Cost Reality of Medical Cannabis in Australia
Initial consultations range from around $69 to $150+ depending on the clinic, with follow-ups from $39 to $100. Medication is a separate cost — commonly $100-$450 per month depending on product and dosage, since almost nothing is PBS-subsidised. Total annual costs commonly land between $1,285 and $5,400+. This cost gap is one of the most frequently cited reasons some Australians who explore the medical pathway compare it against grey-market recreational alternatives.
The Future of Legal Cannabis in Australia
The trajectory of Australian cannabis law is toward incremental change, though the pace and shape of further reform remain genuinely uncertain and vary significantly by state.
Closing the Schedule 3 Gap
The most concrete near-term development to watch is whether any manufacturer successfully registers a Schedule 3 low-dose CBD product on the ARTG. Since the pathway opened in 2021, no product has cleared the bar — but ongoing industry investment in the required safety and efficacy data means this could change. If a product succeeds, it would be the first genuinely over-the-counter cannabinoid product available in Australian pharmacies.
State-by-State Decriminalisation
The ACT remains the only Australian jurisdiction with a decriminalisation framework for personal cannabis possession and limited home cultivation (up to two plants per adult, four per household). Other states periodically debate similar reforms, but none has yet followed the ACT's approach. Any further decriminalisation would not create a legal commercial market but would change the risk profile for personal use in that jurisdiction.
Full Legalisation — The Long-Term Question
Federal recreational legalisation with a regulated commercial market has been debated in the Australian Parliament, with a legalisation bill defeated in a Senate vote in November 2024. The economic and public health arguments echo those made in Canada, Germany, and parts of the US — regulated quality standards, age verification, and tax revenue versus enforcement cost. The political path to a federal regulated market remains distant, and any near-term change is more likely to come through state-based reform or expanded medical access than full legalisation.
Browse All Leaflybuds Products
Five categories, all independently lab-tested, all available for same-day dispatch Monday–Friday before 2pm from our Sydney and Melbourne hubs.
Ready to Order Premium THC Flower?
Lab-tested Cali genetics, same-day dispatch before 2pm, Australia Post Express Tracked. 10,000+ verified Australian reviews · 4.70★
Shop THC Flower Australia →